Kajian klinikal HIV di Michigan
4 kajian untuk HIV sedang mencari peserta di lokasi di Michigan.
Teks kajian rasmi (Bahasa Inggeris)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Be Well Medical Center, Berkley
- Henry Ford Health, Detroit
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Grosse Pointe Woods
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Henry Ford Hospital ( Site 1535), Detroit
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07266831Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Be Well Medical Center, Berkley
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07682961Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.